{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29784973", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "21"}], "Language": ["eng"], "ELocationID": ["580", "10.1038/s41419-018-0661-3"], "Journal": {"ISSN": "2041-4889", "JournalIssue": {"Volume": "9", "Issue": "6", "PubDate": {"Year": "2018", "Month": "May", "Day": "21"}}, "Title": "Cell death & disease", "ISOAbbreviation": "Cell Death Dis"}, "ArticleTitle": "Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.", "Pagination": {"StartPage": "580", "MedlinePgn": "580"}, "Abstract": {"AbstractText": ["Prohibitin (PHB) was originally isolated and characterized as an anti-proliferative gene in rat liver. The evolutionarily conserved PHB gene encodes two human protein isoforms with molecular weights of ~33\u2009kDa, PHB1 and PHB2. PHB1 and PHB2 belong to the prohibitin domain family, and both are widely distributed in different cellular compartments such as the mitochondria, nucleus, and cell membrane. Most studies have confirmed differential expression of PHB1 and PHB2 in cancers compared to corresponding normal tissues. Furthermore, studies verified that PHB1 and PHB2 are involved in the biological processes of tumorigenesis, including cancer cell proliferation, apoptosis, and metastasis. Two small molecule inhibitors, Rocaglamide (RocA) and fluorizoline, derived from medicinal plants, were demonstrated to interact directly with PHB1 and thus inhibit the interaction of PHB with Raf-1, impeding Raf-1/ERK signaling cascades and significantly suppressing cancer cell metastasis. In addition, a short peptide ERAP and a natural product xanthohumol were shown to target PHB2 directly and prohibit cancer progression in estrogen-dependent cancers. As more efficient biomarkers and targets are urgently needed for cancer diagnosis and treatment, here we summarize the functional role of prohibitin domain family proteins, focusing on PHB1 and PHB2 in tumorigenesis and cancer development, with the expectation that targeting the prohibitin domain family will offer more clues for cancer therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 510632, Guangzhou, China."}], "LastName": "Yang", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 510632, Guangzhou, China. libin2015@jnu.edu.cn."}], "LastName": "Li", "ForeName": "Bin", "Initials": "B"}, {"Identifier": ["0000-0003-0503-9492"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, 510632, Guangzhou, China. tqyhe@jnu.edu.cn."}], "LastName": "He", "ForeName": "Qing-Yu", "Initials": "QY"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Death Dis", "NlmUniqueID": "101524092"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "PHB protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "PHB2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Phb protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Prohibitins"}, {"RegistryNumber": "0", "NameOfSubstance": "Repressor Proteins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pathology"], "DescriptorName": "Carcinogenesis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Targeted Therapy"}, {"QualifierName": ["diagnosis", "therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Prohibitins"}, {"QualifierName": [], "DescriptorName": "Protein Domains"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Repressor Proteins"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "McClung JK, et al. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem. Biophys. Res. Commun. 1989;164:1316\u20131322. doi: 10.1016/0006-291X(89)91813-5.", "ArticleIdList": ["10.1016/0006-291X(89)91813-5", "2480116"]}, {"Citation": "Sato T, et al. The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics. 1993;17:762\u2013764. doi: 10.1006/geno.1993.1402.", "ArticleIdList": ["10.1006/geno.1993.1402", "8244394"]}, {"Citation": "Sato T, et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res. 1992;52:1643\u20131646.", "ArticleIdList": ["1540973"]}, {"Citation": "White JJ, et al. Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics. 1991;11:228\u2013230. doi: 10.1016/0888-7543(91)90126-Y.", "ArticleIdList": ["10.1016/0888-7543(91)90126-Y", "1684951"]}, {"Citation": "Mishra S, Murphy LC, Nyomba BL, Murphy LJ. Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 2005;11:192\u2013197. doi: 10.1016/j.molmed.2005.02.004.", "ArticleIdList": ["10.1016/j.molmed.2005.02.004", "15823758"]}, {"Citation": "Nijtmans LG, et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000;19:2444\u20132451. doi: 10.1093/emboj/19.11.2444.", "ArticleIdList": ["10.1093/emboj/19.11.2444", "PMC212747", "10835343"]}, {"Citation": "Tatsuta T, Langer T. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 2008;27:306\u201314.14. doi: 10.1038/sj.emboj.7601972.", "ArticleIdList": ["10.1038/sj.emboj.7601972", "PMC2234350", "18216873"]}, {"Citation": "Wintachai P, et al. Identification of prohibitin as a Chikungunya virus receptor protein. J. Med. Virol. 2012;84:1757\u20131770. doi: 10.1002/jmv.23403.", "ArticleIdList": ["10.1002/jmv.23403", "22997079"]}, {"Citation": "Desideri E, Cavallo AL, Baccarini M. Alike but different: RAF paralogs and their signaling outputs. Cell. 2015;161:967\u2013970. doi: 10.1016/j.cell.2015.04.045.", "ArticleIdList": ["10.1016/j.cell.2015.04.045", "26000477"]}, {"Citation": "Fu P, Yang Z, Bach LA. Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration. J. Biol. Chem. 2013;288:29890\u201329900. doi: 10.1074/jbc.M113.510826.", "ArticleIdList": ["10.1074/jbc.M113.510826", "PMC3795287", "24003225"]}, {"Citation": "Chowdhury I, Thomas K, Thompson WE. Prohibitin(PHB) roles in granulosa cell physiology. Cell Tissue Res. 2016;363:19\u201329. doi: 10.1007/s00441-015-2302-9.", "ArticleIdList": ["10.1007/s00441-015-2302-9", "PMC4842340", "26496733"]}, {"Citation": "Koushyar S, et al. The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells. Oncogenesis. 2017;6:e333. doi: 10.1038/oncsis.2017.32.", "ArticleIdList": ["10.1038/oncsis.2017.32", "PMC5523065", "28504694"]}, {"Citation": "Takata H, et al. PHB2 protects sister-chromatid cohesion in mitosis. Curr. Biol. 2007;17:1356\u20131361. doi: 10.1016/j.cub.2007.07.009.", "ArticleIdList": ["10.1016/j.cub.2007.07.009", "17656096"]}, {"Citation": "Chiu CF, et al. Raf activation by Ras and promotion of cellular metastasis require phosphorylation of prohibitin in the raft domain of the plasma membrane. Oncogene. 2013;32:777\u2013787. doi: 10.1038/onc.2012.86.", "ArticleIdList": ["10.1038/onc.2012.86", "22410782"]}, {"Citation": "Liu P, et al. Prohibitin promotes androgen receptor activation in ER-positive breast cancer. Cell Cycle. 2017;16:776\u2013784. doi: 10.1080/15384101.2017.1295193.", "ArticleIdList": ["10.1080/15384101.2017.1295193", "PMC5405713", "28272969"]}, {"Citation": "Kuramori C, et al. Capsaicin binds to prohibitin 2 and displaces it from the mitochondria to the nucleus. Biochem. Biophys. Res. Commun. 2009;379:519\u2013525. doi: 10.1016/j.bbrc.2008.12.103.", "ArticleIdList": ["10.1016/j.bbrc.2008.12.103", "19116139"]}, {"Citation": "Liao Q, et al. Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis. Eur. J. Cancer Prev. 2013;22:68\u201376. doi: 10.1097/CEJ.0b013e328354d351.", "ArticleIdList": ["10.1097/CEJ.0b013e328354d351", "22728421"]}, {"Citation": "Feng F, Qiu B, Zang R, Song P, Gao S. Pseudogene PHBP1 promotes esophageal squamous cell carcinoma proliferation by increasing its cognate gene PHB expression. Oncotarget. 2017;8:29091\u201329100.", "ArticleIdList": ["PMC5438715", "28404970"]}, {"Citation": "P\u00e9rez-Perarnau A, et al. A trifluorinated thiazoline scaffold leading to pro-apoptotic agents targeting prohibitins. Angew. Chem. Int. Ed. Engl. 2014;53:10150\u201310154. doi: 10.1002/anie.201405758.", "ArticleIdList": ["10.1002/anie.201405758", "25196378"]}, {"Citation": "Kim S, Salim AA, Swanson SM, Kinghorn AD. Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med. Chem. 2006;6:319\u2013345. doi: 10.2174/187152006777698123.", "ArticleIdList": ["10.2174/187152006777698123", "16842234"]}, {"Citation": "Ebada SS, Lajkiewicz N, Porco JA, Jr, Li-Weber M, Proksch P. Chemistry and biology of rocaglamides (=flavaglines) and related derivatives from aglaia species (meliaceae) Prog. Chem. Org. Nat. Prod. 2011;94:1\u201358.", "ArticleIdList": ["PMC4157394", "21833837"]}, {"Citation": "Luan Z, He Y, Alattar M, Chen Z, He F. Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma. Mol. Cancer. 2014;13:38. doi: 10.1186/1476-4598-13-38.", "ArticleIdList": ["10.1186/1476-4598-13-38", "PMC3938031", "24568222"]}, {"Citation": "Doudican NA, Orlow SJ. Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib. Oncogene. 2017;36:423\u2013428. doi: 10.1038/onc.2016.214.", "ArticleIdList": ["10.1038/onc.2016.214", "27321184"]}, {"Citation": "Yoshimaru T, et al. Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat. Commun. 2013;4:2443. doi: 10.1038/ncomms3443.", "ArticleIdList": ["10.1038/ncomms3443", "PMC3791465", "24051437"]}, {"Citation": "Yoshimaru T, et al. Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer. Cancer Sci. 2015;106:550\u2013558. doi: 10.1111/cas.12654.", "ArticleIdList": ["10.1111/cas.12654", "PMC4452155", "25736224"]}, {"Citation": "Morrow IC, et al. Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. J. Biol. Chem. 2002;277:48834\u201348841. doi: 10.1074/jbc.M209082200.", "ArticleIdList": ["10.1074/jbc.M209082200", "12370178"]}, {"Citation": "Bavelloni A, Piazzi M, Raffini M, Faenza I, Blalock WL. Prohibitin 2: At a communications crossroads. IUBMB Life. 2015;67:239\u2013254. doi: 10.1002/iub.1366.", "ArticleIdList": ["10.1002/iub.1366", "25904163"]}, {"Citation": "Back JW, et al. A structure for the yeast prohibitin complex: structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 2002;11:2471\u20132478. doi: 10.1110/ps.0212602.", "ArticleIdList": ["10.1110/ps.0212602", "PMC2373692", "12237468"]}, {"Citation": "L\u00f3pez-Huertas MR, et al. The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4\u2009+\u2009T lymphocytes: a potential mechanism for persistent viral production. J. Biol. Chem. 2013;288:7626\u20137644. doi: 10.1074/jbc.M112.408294.", "ArticleIdList": ["10.1074/jbc.M112.408294", "PMC3597804", "23364796"]}, {"Citation": "Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol. Metab. 2009;20:394\u2013401. doi: 10.1016/j.tem.2009.04.004.", "ArticleIdList": ["10.1016/j.tem.2009.04.004", "19733482"]}, {"Citation": "Ising C, Brinkkoetter PT. Prohibitin signaling at the kidney filtration barrier. Adv. Exp. Med. Biol. 2017;982:563\u2013575. doi: 10.1007/978-3-319-55330-6_29.", "ArticleIdList": ["10.1007/978-3-319-55330-6_29", "28551807"]}, {"Citation": "Bollu LR, et al. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells. Cell Cycle. 2014;13:2415\u20132430. doi: 10.4161/cc.29338.", "ArticleIdList": ["10.4161/cc.29338", "PMC4128886", "25483192"]}, {"Citation": "Moncunill-Massaguer C, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750\u201341765. doi: 10.18632/oncotarget.6154.", "ArticleIdList": ["10.18632/oncotarget.6154", "PMC4747186", "26497683"]}, {"Citation": "Yang HB, et al. Differential expression and regulation of prohibitin during curcumin-induced apoptosis of immortalized human epidermal HaCaT cells. Int. J. Mol. Med. 2014;33:507\u2013514. doi: 10.3892/ijmm.2014.1621.", "ArticleIdList": ["10.3892/ijmm.2014.1621", "PMC3926502", "24402549"]}, {"Citation": "Ising C, et al. Prohibitin-2 depletion unravels extra-mitochondrial functions at the kidney filtration barrier. Am. J. Pathol. 2016;186:1128\u20131139. doi: 10.1016/j.ajpath.2015.12.018.", "ArticleIdList": ["10.1016/j.ajpath.2015.12.018", "27105734"]}, {"Citation": "Lach\u00e9n-Montes M, et al. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer\u2019s disease progression. Sci. Rep. 2017;7:9115. doi: 10.1038/s41598-017-09481-x.", "ArticleIdList": ["10.1038/s41598-017-09481-x", "PMC5567385", "28831118"]}, {"Citation": "Merkwirth C, et al. Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration. PLoS Genet. 2012;8:e1003021. doi: 10.1371/journal.pgen.1003021.", "ArticleIdList": ["10.1371/journal.pgen.1003021", "PMC3493444", "23144624"]}, {"Citation": "Kahl, A. et al. Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2017; 10.1177/0271678X17720371.", "ArticleIdList": ["PMC5999007", "28714328"]}, {"Citation": "Zhou P, et al. Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J. Neurosci. 2012;32:583\u2013592. doi: 10.1523/JNEUROSCI.2849-11.2012.", "ArticleIdList": ["10.1523/JNEUROSCI.2849-11.2012", "PMC3287080", "22238093"]}, {"Citation": "Dutta, D., et al. Low levels of prohibitin in substantia nigra makes dopaminergic neurons vulnerable in Parkinson\u2019s disease. Mol. Neurobiol. 2017; 10.1007/s12035-016-0328-y.", "ArticleIdList": ["28062948"]}, {"Citation": "Chai RR, et al. Prohibitin involvement in the generation of mitochondrial superoxide at complex I in human sperm. J. Cell Mol. Med. 2017;21:121\u2013129. doi: 10.1111/jcmm.12945.", "ArticleIdList": ["10.1111/jcmm.12945", "PMC5192824", "27558591"]}, {"Citation": "Wei Y, Chiang WC, Sumpter R, Jr, Mishra P, Levine B. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell. 2017;168:224\u2013238. doi: 10.1016/j.cell.2016.11.042.", "ArticleIdList": ["10.1016/j.cell.2016.11.042", "PMC5235968", "28017329"]}, {"Citation": "Toska E, Shandilya J, Goodfellow SJ, Medler KF, Roberts SG. Prohibitin is required for transcriptional repression by the WT1-BASP1 complex. Oncogene. 2014;33:5100\u20135108. doi: 10.1038/onc.2013.447.", "ArticleIdList": ["10.1038/onc.2013.447", "PMC4002674", "24166496"]}, {"Citation": "Gamble SC, et al. Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene. 2004;23:2996\u20133004. doi: 10.1038/sj.onc.1207444.", "ArticleIdList": ["10.1038/sj.onc.1207444", "14968116"]}, {"Citation": "Wang S, Nath N, Adlam M, Chellappan S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 1999;18:3501\u20133510. doi: 10.1038/sj.onc.1202684.", "ArticleIdList": ["10.1038/sj.onc.1202684", "10376528"]}, {"Citation": "He B, et al. A repressive role for prohibitin in estrogen signaling. Mol. Endocrinol. 2008;22:344\u2013360. doi: 10.1210/me.2007-0400.", "ArticleIdList": ["10.1210/me.2007-0400", "PMC2234581", "17932104"]}, {"Citation": "Dong P, et al. Induction of paclitaxel resistance by ER\u03b1 mediated prohibitin mitochondrial-nuclear shuttling. PLoS One. 2013;8:e83519. doi: 10.1371/journal.pone.0083519.", "ArticleIdList": ["10.1371/journal.pone.0083519", "PMC3871534", "24376711"]}, {"Citation": "Teittinen KJ, et al. Nucleolar proteins with altered expression in leukemic cell lines. Leuk. Res. 2012;36:232\u2013236. doi: 10.1016/j.leukres.2011.06.038.", "ArticleIdList": ["10.1016/j.leukres.2011.06.038", "21783252"]}, {"Citation": "Shen Y, et al. Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration. Int. J. Mol. Med. 2018;41:1147\u20131155.", "ArticleIdList": ["29207197"]}, {"Citation": "Bavelloni A, et al. Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. FASEB J. 2014;28:2009\u20132019. doi: 10.1096/fj.13-244368.", "ArticleIdList": ["10.1096/fj.13-244368", "24522204"]}, {"Citation": "Knopf JD, et al. The stromal cell-surface protease fibroblast activation protein-\u03b1 localizes to lipid rafts and is recruited to invadopodia. Biochim. Biophys. Acta. 2015;1853(10 Pt A):2515\u20132525. doi: 10.1016/j.bbamcr.2015.07.013.", "ArticleIdList": ["10.1016/j.bbamcr.2015.07.013", "26209915"]}, {"Citation": "Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J. Recept. Signal. Transduct. Res. 2013;33:28\u201336. doi: 10.3109/10799893.2012.752006.", "ArticleIdList": ["10.3109/10799893.2012.752006", "23327602"]}, {"Citation": "Peng YT, Chen P, Ouyang RY, Song L. Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis. 2015;20:1135\u20131149. doi: 10.1007/s10495-015-1143-z.", "ArticleIdList": ["10.1007/s10495-015-1143-z", "PMC4531144", "26091791"]}, {"Citation": "Liu C, et al. Identification of human host proteins contributing to H5N1 influenza virus propagation by membrane proteomics. J. Proteome Res. 2012;11:5396\u20135405. doi: 10.1021/pr3006342.", "ArticleIdList": ["10.1021/pr3006342", "22985253"]}, {"Citation": "Paingankar MS, Gokhale MD, Deobagkar DN. Dengue-2-virus-interacting polypeptides involved in mosquito cell infection. Arch. Virol. 2010;155:1453\u20131461. doi: 10.1007/s00705-010-0728-7.", "ArticleIdList": ["10.1007/s00705-010-0728-7", "20571839"]}, {"Citation": "Yurugi H, et al. Expression of prohibitins on the surface of activated T cells. Biochem. Biophys. Res. Commun. 2012;420:275\u2013280. doi: 10.1016/j.bbrc.2012.02.149.", "ArticleIdList": ["10.1016/j.bbrc.2012.02.149", "22417827"]}, {"Citation": "Santhanam SK, Dutta D, Parween F, Qadri A. The virulence polysaccharide Vi released by Salmonella Typhi targets membrane prohibitin to inhibit T-cell activation. J. Infect. Dis. 2014;210:79\u201388. doi: 10.1093/infdis/jiu064.", "ArticleIdList": ["10.1093/infdis/jiu064", "24470505"]}, {"Citation": "Sharma A, Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl Acad. Sci. USA. 2004;101:17492\u201317497. doi: 10.1073/pnas.0407536101.", "ArticleIdList": ["10.1073/pnas.0407536101", "PMC536020", "15576509"]}, {"Citation": "Zhong N, Cui Y, Zhou X, Li T, Han J. Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS. Tumour Biol. 2015;36:1221\u20131231. doi: 10.1007/s13277-014-2742-y.", "ArticleIdList": ["10.1007/s13277-014-2742-y", "25344214"]}, {"Citation": "Zhang Y, Wang Y, Xiang Y, Lee W, Zhang Y. Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation. J. Thromb. Haemost. 2012;10:411\u2013418. doi: 10.1111/j.1538-7836.2011.04607.x.", "ArticleIdList": ["10.1111/j.1538-7836.2011.04607.x", "22212092"]}, {"Citation": "Wang YJ, et al. Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1. Biochim. Biophys. Acta. 2014;1843:1393\u20131401. doi: 10.1016/j.bbamcr.2014.04.005.", "ArticleIdList": ["10.1016/j.bbamcr.2014.04.005", "24732013"]}, {"Citation": "Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science357, eaan2507 (2017).", "ArticleIdList": ["28818916"]}, {"Citation": "Zhang W, et al. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation. Cell Cycle. 2016;15:1344\u20131351. doi: 10.1080/15384101.2016.1160986.", "ArticleIdList": ["10.1080/15384101.2016.1160986", "PMC4889242", "27111245"]}, {"Citation": "Du MD, He KY, Qin G, Chen J, Li JY. Adriamycin resistance-associated prohibitin gene inhibits proliferation of human osteosarcoma MG63 cells by interacting with oncogenes and tumor suppressor genes. Oncol. Lett. 2016;12:1994\u20132000. doi: 10.3892/ol.2016.4862.", "ArticleIdList": ["10.3892/ol.2016.4862", "PMC4998567", "27602127"]}, {"Citation": "Chumbalkar VC, et al. Differential protein expression in human gliomas and molecular insights. Proteomics. 2005;5:1167\u20131177. doi: 10.1002/pmic.200401202.", "ArticleIdList": ["10.1002/pmic.200401202", "15759318"]}, {"Citation": "Qian X, et al. MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin. CNS Neurosci. Ther. 2013;19:804\u2013812. doi: 10.1111/cns.12195.", "ArticleIdList": ["10.1111/cns.12195", "PMC6493457", "23870455"]}, {"Citation": "Lu JJ, et al. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D. Chin. J. Nat. Med. 2015;13:673\u2013679.", "ArticleIdList": ["26412427"]}, {"Citation": "Cao Y, et al. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. J. Exp. Clin. Cancer Res. 2016;35:68. doi: 10.1186/s13046-016-0346-7.", "ArticleIdList": ["10.1186/s13046-016-0346-7", "PMC4833931", "27084680"]}, {"Citation": "Jiang L, et al. Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death Dis. 2015;6:e1660. doi: 10.1038/cddis.2015.40.", "ArticleIdList": ["10.1038/cddis.2015.40", "PMC4669803", "25719244"]}, {"Citation": "Wu TF, et al. Prohibitin in the pathogenesis of transitional cell bladder cancer. Anticancer Res. 2007;27:895\u2013900.", "ArticleIdList": ["17465217"]}, {"Citation": "El-Etreby NM, Ghazy AA, Rashad R. Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-\u03b2 pathways. J. Ovarian Res. 2017;10:28. doi: 10.1186/s13048-017-0325-4.", "ArticleIdList": ["10.1186/s13048-017-0325-4", "PMC5399399", "28427435"]}, {"Citation": "Dai Z, et al. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines. Proteomics. 2010;10:3789\u20133799. doi: 10.1002/pmic.200900685.", "ArticleIdList": ["10.1002/pmic.200900685", "20957754"]}, {"Citation": "Nakamura A, Osonoi T, Terauchi Y. Relationship between urinary sodium excretion and pioglitazone-induced edema. J. Diabetes Investig. 2010;1:208\u2013211. doi: 10.1111/j.2040-1124.2010.00046.x.", "ArticleIdList": ["10.1111/j.2040-1124.2010.00046.x", "PMC4020723", "24843434"]}, {"Citation": "Kim NH, et al. BIG3 inhibits the estrogen-dependent nuclear translocation of PHB2 via multiple karyopherin-alpha proteins in breast cancer cells. PLoS One. 2015;10:e0127707. doi: 10.1371/journal.pone.0127707.", "ArticleIdList": ["10.1371/journal.pone.0127707", "PMC4460025", "26052702"]}, {"Citation": "Cheng J, et al. Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy. Mol. Carcinog. 2014;53:820\u2013832. doi: 10.1002/mc.22040.", "ArticleIdList": ["10.1002/mc.22040", "23661548"]}, {"Citation": "Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352:169\u2013175. doi: 10.1126/science.aaf2784.", "ArticleIdList": ["10.1126/science.aaf2784", "27124450"]}, {"Citation": "Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u2013691. doi: 10.1016/j.cell.2016.11.037.", "ArticleIdList": ["10.1016/j.cell.2016.11.037", "PMC5308465", "28187288"]}, {"Citation": "Massagu\u00e9 J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306. doi: 10.1038/nature17038.", "ArticleIdList": ["10.1038/nature17038", "PMC5029466", "26791720"]}, {"Citation": "Chiu CF, Peng JM, Hung SW, Liang CM, Liang SM. Recombinant viral capsid protein VP1 suppresses migration and invasion of human cervical cancer by modulating phosphorylated prohibitin in lipid rafts. Cancer Lett. 2012;320:205\u2013214. doi: 10.1016/j.canlet.2012.02.027.", "ArticleIdList": ["10.1016/j.canlet.2012.02.027", "22388104"]}, {"Citation": "Ma LL, et al. Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells. Oncotarget. 2017;8:76340\u201376356.", "ArticleIdList": ["PMC5652710", "29100316"]}, {"Citation": "Ho MY, Liang CM, Liang SM. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis. Oncotarget. 2015;6:381\u2013393.", "ArticleIdList": ["PMC4381602", "25575814"]}, {"Citation": "Wong PF, et al. Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine. 2012;19:138\u2013144. doi: 10.1016/j.phymed.2011.07.001.", "ArticleIdList": ["10.1016/j.phymed.2011.07.001", "21903368"]}, {"Citation": "Canevari RA, et al. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma. Tumour Biol. 2016;37:13855\u201313870. doi: 10.1007/s13277-016-5133-8.", "ArticleIdList": ["10.1007/s13277-016-5133-8", "27485113"]}, {"Citation": "Koushyar S, Jiang WG, Dart DA. Unveiling the potential of prohibitin in cancer. Cancer Lett. 2015;369:316\u2013322. doi: 10.1016/j.canlet.2015.09.012.", "ArticleIdList": ["10.1016/j.canlet.2015.09.012", "26450374"]}, {"Citation": "Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742\u2013758. doi: 10.1016/j.cell.2011.10.033.", "ArticleIdList": ["10.1016/j.cell.2011.10.033", "PMC4511103", "22078876"]}, {"Citation": "Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science. 2014;345:1250256. doi: 10.1126/science.1250256.", "ArticleIdList": ["10.1126/science.1250256", "PMC4219413", "25237106"]}, {"Citation": "Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature. 2006;443:796\u2013802. doi: 10.1038/nature05293.", "ArticleIdList": ["10.1038/nature05293", "PMC3970704", "17051206"]}, {"Citation": "Evan GerardI, Vousden KarenH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u2013348. doi: 10.1038/35077213.", "ArticleIdList": ["10.1038/35077213", "11357141"]}, {"Citation": "Lowe ScottW, Cepero Enrique, Evan Gerard. Intrinsic tumour suppression. Nature. 2004;432:307\u2013315. doi: 10.1038/nature03098.", "ArticleIdList": ["10.1038/nature03098", "15549092"]}, {"Citation": "Croce CM, Reed JC. Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res. 2016;76:5914\u20135920. doi: 10.1158/0008-5472.CAN-16-1248.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-1248", "PMC5117672", "27694602"]}, {"Citation": "Igea A, Nebreda AR. The Stress Kinase p38\u03b1 as a Target for Cancer Therapy. Cancer Res. 2015;75:3997\u20134002. doi: 10.1158/0008-5472.CAN-15-0173.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-0173", "26377941"]}, {"Citation": "Guan X, Liu Z, Wang L, Johnson DG, Wei Q. Identification of prohibitin and prohibiton as novel factors binding to the p53 induced gene 3 (PIG3) promoter (TGYCC)(15) motif. Biochem. Biophys. Res. Commun. 2014;443:1239\u20131244. doi: 10.1016/j.bbrc.2013.12.124.", "ArticleIdList": ["10.1016/j.bbrc.2013.12.124", "PMC4155496", "24388982"]}, {"Citation": "Zhang W, et al. BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner. Oncotarget. 2015;6:7608\u20137618.", "ArticleIdList": ["PMC4480703", "25797244"]}, {"Citation": "Dong P, Flores J, Pelton K, Solomon KR. Prohibitin is a cholesterol-sensitive regulator of cell cycle transit. J. Cell. Biochem. 2010;111:1367\u20131374. doi: 10.1002/jcb.22865.", "ArticleIdList": ["10.1002/jcb.22865", "20830747"]}, {"Citation": "Liu YH, Peck K, Lin JY. Involvement of prohibitin upregulation in abrin-triggered apoptosis. Evid. Based Complement. Altern. Med. 2012;2012:605154.", "ArticleIdList": ["PMC3179879", "21961024"]}, {"Citation": "Liu Y, He P, Zhang M, Wu D. Lentiviral vector-mediated RNA interference targeted against prohibitin inhibits apoptosis of the retinoic acid-resistant acute promyelocytic leukemia cell line NB4-R1. Mol. Med. Rep. 2012;6:1288\u20131292. doi: 10.3892/mmr.2012.1105.", "ArticleIdList": ["10.3892/mmr.2012.1105", "23023919"]}, {"Citation": "Song W, Tian L, Li SS, Shen DY, Chen QX. The aberrant expression and localization of prohibitin during apoptosis of human cholangiocarcinoma Mz-ChA-1 cells. FEBS Lett. 2014;588:422\u2013428. doi: 10.1016/j.febslet.2013.12.021.", "ArticleIdList": ["10.1016/j.febslet.2013.12.021", "24380853"]}, {"Citation": "Zhang L, Ji Q, Ni ZH, Sun J. Prohibitin induces apoptosis in BGC823 gastric cancer cells through the mitochondrial pathway. Asian Pac. J. Cancer Prev. 2012;13:3803\u20133807. doi: 10.7314/APJCP.2012.13.8.3803.", "ArticleIdList": ["10.7314/APJCP.2012.13.8.3803", "23098474"]}, {"Citation": "Yoo DR, et al. Proteomic identification of anti-cancer proteins in luteolin-treated human hepatoma Huh-7 cells. Cancer Lett. 2009;282:48\u201354. doi: 10.1016/j.canlet.2009.02.051.", "ArticleIdList": ["10.1016/j.canlet.2009.02.051", "19342156"]}, {"Citation": "Xu DH, et al. Positional and expressive alteration of prohibitin during the induced differentiation of human hepatocarcinoma SMMC-7721 cells. World J. Gastroenterol. 2008;14:5008\u20135014. doi: 10.3748/wjg.14.5008.", "ArticleIdList": ["10.3748/wjg.14.5008", "PMC2742927", "18763282"]}, {"Citation": "Li QF, et al. Localization of prohibitin in the nuclear matrix and alteration of its expression during differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. Cell. Mol. Neurobiol. 2011;31:203\u2013211. doi: 10.1007/s10571-010-9608-7.", "ArticleIdList": ["10.1007/s10571-010-9608-7", "21061155"]}, {"Citation": "Hnisz D, Shrinivas K, Young RA, Chakraborty AK, Sharp PA. A Phase Separation Model for Transcriptional Control. Cell. 2017;169:13\u201323. doi: 10.1016/j.cell.2017.02.007.", "ArticleIdList": ["10.1016/j.cell.2017.02.007", "PMC5432200", "28340338"]}, {"Citation": "Bradner JE, Hnisz D, Young RA. Transcriptional addiction in cancer. Cell. 2017;168:629\u2013643. doi: 10.1016/j.cell.2016.12.013.", "ArticleIdList": ["10.1016/j.cell.2016.12.013", "PMC5308559", "28187285"]}, {"Citation": "Popovitchenko T, Rasin MR. Transcriptional and post-transcriptional mechanisms of the development of neocortical lamination. Front. Neuroanat. 2017;11:102. doi: 10.3389/fnana.2017.00102.", "ArticleIdList": ["10.3389/fnana.2017.00102", "PMC5684109", "29170632"]}, {"Citation": "Liu W, Ma R, Yuan Y. Post-transcriptional Regulation of Genes Related to Biological Behaviors of Gastric Cancer by Long Noncoding RNAs and MicroRNAs. J. Cancer. 2017;8:4141\u20134154. doi: 10.7150/jca.22076.", "ArticleIdList": ["10.7150/jca.22076", "PMC5706018", "29187891"]}, {"Citation": "Liang Z, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017;411:90\u201399. doi: 10.1016/j.canlet.2017.09.046.", "ArticleIdList": ["10.1016/j.canlet.2017.09.046", "28987385"]}, {"Citation": "Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature. 2003;426:895\u2013899. doi: 10.1038/nature02263.", "ArticleIdList": ["10.1038/nature02263", "14685250"]}, {"Citation": "Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature. 2016;529:326\u2013335. doi: 10.1038/nature17041.", "ArticleIdList": ["10.1038/nature17041", "26791723"]}, {"Citation": "Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431\u2013436. doi: 10.1038/nature04870.", "ArticleIdList": ["10.1038/nature04870", "16724054"]}, {"Citation": "Sch\u00fcbeler D. Function and information content of DNA methylation. Nature. 2015;517:321\u2013326. doi: 10.1038/nature14192.", "ArticleIdList": ["10.1038/nature14192", "25592537"]}, {"Citation": "Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature. 2010;467:415\u2013419. doi: 10.1038/nature09351.", "ArticleIdList": ["10.1038/nature09351", "20864994"]}, {"Citation": "Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature. 2009;457:426\u2013433. doi: 10.1038/nature07758.", "ArticleIdList": ["10.1038/nature07758", "PMC2702667", "19158789"]}, {"Citation": "Leal MF, et al. Prohibitin expression deregulation in gastric cancer is associated with the 3\u2019 untranslated region 1630 C T polymorphism and copy number variation. PLoS One. 2014;9:e98583. doi: 10.1371/journal.pone.0098583.", "ArticleIdList": ["10.1371/journal.pone.0098583", "PMC4039508", "24879411"]}, {"Citation": "Francisco G, et al. Polymorphisms in the p27kip-1 and prohibitin genes denote novel genes associated with melanoma risk in Brazil, a high ultraviolet index region. Melanoma Res. 2013;23:231\u2013236. doi: 10.1097/CMR.0b013e3283612483.", "ArticleIdList": ["10.1097/CMR.0b013e3283612483", "23624368"]}, {"Citation": "Puppin C, Passon N, Franzoni A, Russo D, Damante G. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. Oncol. Rep. 2011;25:393\u2013397.", "ArticleIdList": ["21152868"]}, {"Citation": "Fletcher CE, et al. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer. Hum. Mol. Genet. 2012;21:3112\u20133127. doi: 10.1093/hmg/dds139.", "ArticleIdList": ["10.1093/hmg/dds139", "22505583"]}, {"Citation": "Liu T, Tang H, Lang Y, Liu M, Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009;273:233\u2013242. doi: 10.1016/j.canlet.2008.08.003.", "ArticleIdList": ["10.1016/j.canlet.2008.08.003", "18789835"]}, {"Citation": "Chen W, et al. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol. Med. Rep. 2015;12:1515\u20131523. doi: 10.3892/mmr.2015.3475.", "ArticleIdList": ["10.3892/mmr.2015.3475", "25777779"]}, {"Citation": "Cirilo PDR, et al. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1. BMC Cancer. 2017;17:750. doi: 10.1186/s12885-017-3721-7.", "ArticleIdList": ["10.1186/s12885-017-3721-7", "PMC5681823", "29126391"]}, {"Citation": "Wang K, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat. Commun. 2014;5:3596. doi: 10.1038/ncomms4596.", "ArticleIdList": ["10.1038/ncomms4596", "24710105"]}, {"Citation": "Frankson R, et al. Therapeutic targeting of oncogenic tyrosine phosphatases. Cancer Res. 2017;77:5701\u20135705. doi: 10.1158/0008-5472.CAN-17-1510.", "ArticleIdList": ["10.1158/0008-5472.CAN-17-1510", "PMC5827927", "28855209"]}, {"Citation": "Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126:855\u2013867. doi: 10.1016/j.cell.2006.08.019.", "ArticleIdList": ["10.1016/j.cell.2006.08.019", "16959566"]}, {"Citation": "Bergink S, Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature. 2009;458:461\u2013467. doi: 10.1038/nature07963.", "ArticleIdList": ["10.1038/nature07963", "19325626"]}, {"Citation": "Ande SR, Moulik S, Mishra S. Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch. PLoS One. 2009;4:e4586. doi: 10.1371/journal.pone.0004586.", "ArticleIdList": ["10.1371/journal.pone.0004586", "PMC2642629", "19238206"]}, {"Citation": "Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27:462\u2013472. doi: 10.1016/j.ccell.2015.02.015.", "ArticleIdList": ["10.1016/j.ccell.2015.02.015", "PMC4400235", "25858805"]}, {"Citation": "Wood KC. Mapping the pathways of resistance to targeted therapies. Cancer Res. 2015;75:4247\u20134251. doi: 10.1158/0008-5472.CAN-15-1248.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-1248", "PMC4609261", "26392071"]}, {"Citation": "Ramos P, Bentires-Alj M. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene. 2014;34:3617\u20133626. doi: 10.1038/onc.2014.314.", "ArticleIdList": ["10.1038/onc.2014.314", "25263438"]}, {"Citation": "Chong CR, J\u00e4nne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat. Med. 2013;19:1389\u20131400. doi: 10.1038/nm.3388.", "ArticleIdList": ["10.1038/nm.3388", "PMC4049336", "24202392"]}, {"Citation": "Lord CJ, Ashworth A. Mechanisms of resistance to therapies targeting BRCA-mutant cancers. Nat. Med. 2013;19:1381\u20131388. doi: 10.1038/nm.3369.", "ArticleIdList": ["10.1038/nm.3369", "24202391"]}, {"Citation": "Polier G, et al. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. Chem. Biol. 2012;19:1093\u20131104. doi: 10.1016/j.chembiol.2012.07.012.", "ArticleIdList": ["10.1016/j.chembiol.2012.07.012", "22999878"]}, {"Citation": "Yurugi H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36:4778\u20134789. doi: 10.1038/onc.2017.93.", "ArticleIdList": ["10.1038/onc.2017.93", "28414306"]}, {"Citation": "Cosialls AM, et al. The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax. Haematologica. 2017;102:1587\u20131593. doi: 10.3324/haematol.2016.162958.", "ArticleIdList": ["10.3324/haematol.2016.162958", "PMC5685241", "28619845"]}, {"Citation": "Yoshimaru T, et al. Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics. Sci. Rep. 2017;7:1821. doi: 10.1038/s41598-017-01951-6.", "ArticleIdList": ["10.1038/s41598-017-01951-6", "PMC5431889", "28500289"]}, {"Citation": "Yoshimaru T, et al. Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions. Sci. Rep. 2014;4:7355. doi: 10.1038/srep07355.", "ArticleIdList": ["10.1038/srep07355", "PMC4258681", "25483453"]}, {"Citation": "Gan HK, Burgess AW, Clayton AH, Scott AM. Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy. Cancer Res. 2012;72:2924\u20132930. doi: 10.1158/0008-5472.CAN-11-3898.", "ArticleIdList": ["10.1158/0008-5472.CAN-11-3898", "22659454"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "15"}, {"Year": "2018", "Month": "5", "Day": "3"}, {"Year": "2018", "Month": "4", "Day": "27"}, {"Year": "2018", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["29784973", "PMC5962566", "10.1038/s41419-018-0661-3", "10.1038/s41419-018-0661-3"]}}]}